logo
Select company
Select metric
$ -24.58EBITDA per Share
VS
Market
1
Sector
2
Industry
2
History
100
$ 5.8Close
$ 4.78 - $ 13.59 52-Week Range
Ticker Information

Ticker

BOLT

Company Name

BOLT BIOTHERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BOLT BIOTHERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BOLT - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -47.13M$ -24.5811.92M
3/31/2025$ -59.49M$ -31.0311.92M
12/31/2024$ -59.04M$ -30.9211.91M
9/30/2024$ -60.14M$ -31.4511.91M
6/30/2024$ -61.26M$ -32.1311.91M
3/31/2024$ -58.18M$ -30.5611.9M
12/31/2023$ -64.39M$ -34.0611.89M
9/30/2023$ -66.54M$ -35.1411.89M
6/30/2023$ -72.13M$ -38.2111.89M
3/31/2023$ -76.85M$ -40.7911.88M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BOLT BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ 0.
  • Over the past 5 years, BOLT BIOTHERAPEUTICS INC's average EBITDAPS has been $ -69.76.
  • The median EBITDAPS for BOLT BIOTHERAPEUTICS INC during this period was $ -38.21
  • BOLT BIOTHERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ -24.58.
  • The lowest EBITDAPS recorded by BOLT BIOTHERAPEUTICS INC in the same timeframe $ -553.9

BOLT BIOTHERAPEUTICS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
TRAW : TRAWS PHARMA INC $ 15.1CYCN : CYCLERION THERAPEUTICS INC $ -0.63LPCN : LIPOCINE INC $ -0.83INM : INMED PHARMACEUTICALS INC $ -7.43LGVN : LONGEVERON INC $ -1.16NBY : NOVABAY PHARMACEUTICALS INC $ 0.62MRKR : MARKER THERAPEUTICS INC $ -1.04APRE : APREA THERAPEUTICS INC $ -2.44LYRA : LYRA THERAPEUTICS INC $ -28.45INBS : INTELLIGENT BIO SOLUTIONS INC $ -1.76

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for BOLT BIOTHERAPEUTICS INC is calculated as follows: EBITDA [ $ 0 ] / (Shares WA [ 1.68M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ 0 ]

BOLT - EBITDA per Share, Last 5 years

$ -553.9

Minimum

Dec 31, 2020

$ -24.58

Maximum

Jun 30, 2025

$ -69.76

Average

$ -38.21

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -11.29
max$ 14.03
average$ 2.03
median$ 1
std$ 4.28